INCE Capital — 2023 Investments
2 investments dated 2023 · listed companies and verified rows first · show all
Allorion Therapeutics is a biotech company developing next-generation targeted small-molecule drugs for human diseases, using data-driven discovery platforms and partnerships with pharmaceutical companies for commercialization.
BiotechHealthtech
Co-investorsQiming Venture Partners
LunarCrush analyzes millions of social media posts in real time across networks like X, Reddit, YouTube, TikTok, Instagram, and news to produce sentiment and influence metrics for crypto assets, stocks, brands, and people.
AI & Machine LearningCrypto & Web3Data & InfrastructureFintechCosta Mesa, US
Joe Vezzani(Founder)in
Co-investorsDraper AssociatesLBANK LabsTechstarsTRGCWWVenturesBlockchain Founders Fund+4 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.